SOPH
SOPHiA Genetics SA

252
Mkt Cap
$325.06M
Volume
30,448.00
52W High
$5.30
52W Low
$2.58
PE Ratio
-4.31
SOPH Fundamentals
Price
$4.89
Prev Close
$4.81
Open
$4.83
50D MA
$4.27
Beta
0.87
Avg. Volume
134,788.74
EPS (Annual)
-$0.946
P/B
5.38
Rev/Employee
$154,073.29
Loading...
Loading...
News
all
press releases
Tempus AI's Data Business Is Expanding and Adding to Revenues: Here's How
TEM's surging Insights revenues, new contracts and expanded AI capabilities highlight its shift toward scalable data-driven growth.
Zacks·1d ago
News Placeholder
More News
News Placeholder
Rathbones Group PLC Takes Position in SOPHiA GENETICS SA $SOPH
Rathbones Group PLC acquired a new stake in SOPHiA GENETICS SA (NASDAQ:SOPH - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and...
MarketBeat·13d ago
News Placeholder
SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine
SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to...
PR Newswire·15d ago
News Placeholder
Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT and MSK-ACCESS Assays on DNBSEQ-T1+ Platform at AMP 2025
Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT and MSK-ACCESS Assays on DNBSEQ-T1+ Platform at AMP 2025 Complete Genomics and SOPHiA GENETICS Announce Integration of...
PR Newswire·15d ago
News Placeholder
BTIG Research Boosts SOPHiA GENETICS (NASDAQ:SOPH) Price Target to $7.00
BTIG Research raised their price objective on shares of SOPHiA GENETICS from $6.00 to $7.00 and gave the stock a "buy" rating in a report on Monday...
MarketBeat·15d ago
News Placeholder
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and...
PR Newswire·15d ago
News Placeholder
SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance
SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance PR Newswire BOSTON and...
PR Newswire·22d ago
News Placeholder
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025 SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025 PR Newswire BOSTON...
PR Newswire·1mo ago
News Placeholder
Tempus AI Stock Before Q3 Earnings Release: To Buy or Not to Buy?
TEM's 48% surge, key FDA clearances and bold AI acquisitions set the stage for its Q3 earnings reveal.
Zacks·1mo ago
News Placeholder
A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan
A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan A.D.A.M. Innovations and SOPHiA GENETICS partner to advance...
PR Newswire·1mo ago

Latest SOPH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.